Literature DB >> 2275884

Current antiarrhythmic therapy overview.

A J Camm1.   

Abstract

Cardiac arrhythmias are commonplace in the Western world and vary in their degree of seriousness from benign to life threatening. In general, arrhythmias may be managed in one of five ways: reassurance only, physical maneuvers, antiarrhythmic drugs, implantable electronic devices, and surgical or transvascular ablation. Treatment is designed to terminate ongoing arrhythmias, to prevent recurrence of arrhythmias, or to control the rate of the arrhythmia. Occasionally, the propensity to arrhythmia may be cured by abolition of the anatomic substrate for the arrhythmia. Which of these modalities and approaches to the management of cardiac arrhythmia will be chosen by the physician for any individual patient is very much dependent on the character of the arrhythmia and the patient's underlying disease.

Entities:  

Mesh:

Year:  1990        PMID: 2275884     DOI: 10.1007/bf00357024

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  4 in total

1.  Out-of-hospital cardiac arrest. Use of electrophysiologic testing in the prediction of long-term outcome.

Authors:  D J Wilber; H Garan; D Finkelstein; E Kelly; J Newell; B McGovern; J N Ruskin
Journal:  N Engl J Med       Date:  1988-01-07       Impact factor: 91.245

2.  Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia.

Authors:  W J McKenna; C M Oakley; D M Krikler; J F Goodwin
Journal:  Br Heart J       Date:  1985-04

3.  Vagal techniques for termination of paroxysmal supraventricular tachycardia.

Authors:  M B Waxman; R W Wald; A D Sharma; F Huerta; D A Cameron
Journal:  Am J Cardiol       Date:  1980-10       Impact factor: 2.778

4.  Relative efficacy of various physical manoeuvres in the termination of junctional tachycardia.

Authors:  D Mehta; S Wafa; D E Ward; A J Camm
Journal:  Lancet       Date:  1988-05-28       Impact factor: 79.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.